Today: 23 March 2026
Browse Category

NASDAQ:CLPT 3 November 2025

ClearPoint Neuro (CLPT) Stock Skyrockets on Brain Therapy Breakthroughs – 2025 Deep Dive

ClearPoint Neuro (CLPT) Stock Skyrockets on Brain Therapy Breakthroughs – 2025 Deep Dive

ClearPoint Neuro shares surged to the mid-$20s in November 2025 after hitting a 52-week high near $30, driven by heavy trading and recent product breakthroughs. The company reported Q2 revenue of $9.2 million, up 17% year-on-year, but remains unprofitable. Its neuro devices gained expanded FDA clearance and international approvals. Analysts maintain buy ratings with price targets averaging $29.
3 November 2025

Stock Market Today

  • Avista (AVA) Stock Near Fair Value Amid Recent Price Decline
    March 23, 2026, 4:42 AM EDT. Avista (AVA) shares have fallen 9.4% over 30 days but remain close to intrinsic value. The Dividend Discount Model (DDM) estimates Avista's fair price at $36.78 versus a recent close of $38.37, indicating around a 4.3% premium. The model factors in a dividend of $2.12, a return on equity of 7.1%, and a high payout ratio of 83%, which caps dividend growth at approximately 1.2% annually. Avista's 1-year return of 1.5% trails peers, reflecting sector sentiment shifts and regulatory updates impacting the integrated utilities space. On Simply Wall St's 6-point valuation scale, Avista scores 3 out of 6, signaling a mixed outlook. Investors should monitor valuation changes alongside market developments for timely decisions.
Go toTop